Informations sur le produit
- N-[2-[5-(aminoiminomethyl)-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]-3,5-difluoro-4-pyridinyl]-N-methyl glycineCI 1031Fidexaban
- Zk-807834
- Bx-807834
- ZK-807191(diHCl)
- Pd-200022
- Ci-1031
- N-[(2-{[3-(diaminomethylidene)-6-oxocyclohexa-1,4-dien-1-yl]oxy}-3,5-difluoro-6-[3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridin-4-yl)methyl]glycine
Fidexaban is a low molecular weight heparin with antithrombotic properties. It has been shown to be effective in preventing thrombosis, including pulmonary embolism and deep vein thrombosis, and for the treatment of coronary artery disease. Fidexaban is a competitive inhibitor of heparin that binds to the active site of serine proteases. The binding prevents these enzymes from cleaving the substrate and leads to an increase in soluble guanylate cyclase activity, which inhibits platelet aggregation and reduces blood clotting. Fidexaban also binds to proteins on the surface of red blood cells and inhibits platelet aggregation. This drug is classified as a low molecular weight heparin because it has a molecular weight of less than 5000 Da.
Propriétés chimiques
Question d’ordre technique sur : 3D-FF23284 Fidexaban
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages